David D. Meek

Biography

Mr. David D. Meek has been the Chief Executive Officer of Ipsen S.A. since July 18, 2016. Prior to that, Mr. Meek served as an Executive Vice President and President of Oncology at Baxalta Incorporated until July 2016. He served as Baxter's Vice President, Global Head of Oncology since early 2014. He led the formation of the oncology division and rapidly created an innovative oncology portfolio through strategic acquisitions and partnering deals. He served as Chief Commercial Officer of Endocyte, Inc. from August 2012 to July 2014 and served as its Executive Officer from June 02, 2014 to August 29, 2014. Mr. Meek has more than 25 years of pharmaceutical industry experience, including general management in North America and Europe and numerous successful launches for oncology and specialty products. He served at Novartis Pharma AG for more than seven years, where he served as the head of northern and central Europe oncology and launched key new oncology products and indications for Novartis. Previously, he served as President and Chief Executive Officer of Novartis Pharmaceuticals Canada, where he oversaw the launch of Lucentis and other specialty products and he also served as the global business franchise head for Novartis' respiratory and dermatology franchise in Basel, Switzerland. He was employed at Novartis from 2005 to 2012, where Mr. Meek served as President and Chief Executive Officer of the pharmaceutical division in Canada; and the Head of Oncology for Northern, Central and Eastern Europe, based in Milan, Italy. He started his career at Johnson & Johnson and Janssen Pharmaceutica from 1989 to 2004 where he held a variety of U.S. senior sales and marketing positions across multiple therapeutic areas in primary care (gastroenterology, pain management, dermatology) and specialty care (oncology, neuroscience). Prior to joining Novartis, he was at Johnson & Johnson for 15 years, where he held a variety of senior sales and marketing roles across multiple therapeutic areas, including oncology. He has been Director of Ipsen S.A. since June 7, 2017. Mr. Meek holds a B.A. in management from the University of Cincinnati.

Research Interest

Business&Management